Major Pericarditis Companies in Romania | Key Players 2026

Major Pericarditis Companies in Romania

The following is a data-backed list of the leading Romania Pericarditis companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Romania Pericarditis Industry, including Novartis Romania S.R.L., Sanofi Romania S.R.L., and other established names.

List of Pericarditis companies in Romania:

1. Novartis Romania S.R.L.

Novartis leverages its global expertise in immunology to provide targeted therapies that address the underlying inflammatory signalling pathways in recurrent pericarditis.

2. Sanofi Romania S.R.L.

Sanofi maintains a strong market position by supplying essential anti-inflammatory agents and investing in long-term cardiovascular immunity research.

3. AstraZeneca Romania S.R.L.

AstraZeneca focuses on systemic disease management, providing innovative cardiovascular research and therapies that reduce the burden of heart failure.

4. Terapia S.A. (Sun Pharma Company)

Terapia provides cost-effective, high-quality analgesics and anti-inflammatory medications essential for standard pericarditis treatment protocols.

5. Zentiva S.A.

Zentiva is a cornerstone of the generic market, ensuring broad patient access to vital anti-inflammatory treatments used in cardiac care.

6. Bayer S.R.L.

Bayer contributes specialized cardiovascular therapeutics, providing critical options for secondary management and long-term symptom control in inflammatory heart disease.

7. Pfizer Romania S.R.L.

Pfizer supports the market with a portfolio of foundational anti-inflammatory medications that serve as the pillar for first-line pericarditis treatment in Romania.

8. Gedeon Richter Romania S.A.

Gedeon Richter utilizes its localized production capabilities to provide integrated pharmaceutical solutions that address the specific needs of patients.

9. Antibiotice S.A. Iași

Antibiotice Iași provides essential injectable and oral anti-infective and anti-inflammatory agents, forming a vital component of the hospital treatment supply chain.

10. Bristol Myers Squibb (BMS) Romania

BMS contributes advanced immuno-modulatory expertise, helping to modulate immune-driven reactions in patients suffering from complex pericardial disease.

Frequently Asked Questions About the Market Study (FAQs):